Atopic dermatitis (AD) often begins in infancy and affects up to 25% of children. Topical steroids are often the treatment of choice for inflammatory skin diseases like AD, but they come with unwanted side effects. Current non-steroidal drugs typically use a single or dual-target approach, resulting in suboptimal efficacy. Itch Is the most prevalent, severe, and burdensome symptom of AD.